Generate Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25M Sell
27,197
-20,198
-43% -$20.5M 1.23% 21
2025
Q4
$50.9M Sell
47,395
-34,418
-42% -$32.9M 2.32% 9
2025
Q3
$62.4M Buy
81,813
+15,352
+23% +$11.4M 3.17% 7
2025
Q2
$51.8M Buy
66,461
+42,083
+173% +$32.7M 2.87% 7
2025
Q1
$20.1M Sell
24,378
-7,336
-23% -$6.1M 1.41% 25
2024
Q4
$24.5M Buy
31,714
+16,082
+103% +$13.3M 1.71% 16
2024
Q3
$13.8M Sell
15,632
-12,496
-44% -$11.2M 0.93% 41
2024
Q2
$25.5M Sell
28,128
-3,187
-10% -$2.55M 1.5% 18
2024
Q1
$24.4M Sell
31,315
-7,984
-20% -$5.68M 1.77% 17
2023
Q4
$22.9M Buy
+39,299
New +$22.9M 1.98% 14

Other funds holding LLY

Generate Investment Management's LLY Position: Q1 2026 in Review

Generate Investment Management reduced its Eli Lilly (LLY) stake by 43% in Q1 2026, selling an estimated $20.5M and leaving 27,197 shares worth $25M. The position accounts for 1.23% of the portfolio, ranked #21.

Generate Investment Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $62.4M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Generate Investment Management held 27,197 shares of Eli Lilly worth $25M as of Q1 2026.
  • Generate Investment Management sold 20,198 Eli Lilly shares in Q1 2026, an estimated $20.5M.
  • Eli Lilly made up 1.23% of Generate Investment Management's portfolio in Q1 2026, its #21 holding.
  • Generate Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Generate Investment Management's Eli Lilly position peaked at $62.4M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Generate Investment Management's 13F filing for Q1 2026, filed 16 Apr 2026.